The AMA called for alterations for insurers, including terminating cost-sharing and prior authorization for chronic pain and OUD medications and removing restrictions on Medicaid preferred drug lists.
The study emphasized the need to treat depression and other comorbidities, including anxiety and substance use disorders.
The results provide insights into the underlying causes of relapse and can be used to gain further understanding of the long-term effect of pharmacotherapy for sustained opioid use disorder recovery.
Hepatitis B virus prevalence was 7 to 10 times higher in a homeless population of Los Angeles compared to the general population of the United States.
Researchers examined the association between mental health conditions and the risk for chronic opioid therapy in patients with rheumatoid arthritis.
Women with depression are more than three times more likely to use cannabis during pregnancy compared with women without depression.
In patients with Huntington disease, higher levels of functional impairment and current alcohol consumption were significantly correlated with missing work in multivariate logistic regression analyses.
While socioeconomic status is a known predictor of mental and physical health, the study provided new insights into precise risk relationships and potential cascading trajectories.
Gabapentin appears to be efficacious for the treatment of alcohol use disorder (AUD), especially among those with high alcohol withdrawal.
Healthcare utilization and expenditures on psychiatric and somatic disorders at 18 years were significantly higher in patients with a childhood diagnosis of ADHD for most outcomes.